Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes.

about

Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes.

Item

http://www.wikidata.org/entity/Q38378213

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Relationship Between Peak Trop ...... With Acute Coronary Syndromes.

@en

type

Item

label

Relationship Between Peak Trop ...... With Acute Coronary Syndromes.

@en

prefLabel

Relationship Between Peak Trop ...... With Acute Coronary Syndromes.

@en

P1476

Relationship Between Peak Trop ...... With Acute Coronary Syndromes.

@en

P2093

Christian W Hamm

http://www.w3.org/2001/XMLSchema#string

Derek D Cyr

http://www.w3.org/2001/XMLSchema#string

Eileen B Brown

http://www.w3.org/2001/XMLSchema#string

Harvey D White

http://www.w3.org/2001/XMLSchema#string

Megan Neely

http://www.w3.org/2001/XMLSchema#string

Sarah A Goldstein

http://www.w3.org/2001/XMLSchema#string

P2860

Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes.

P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management.

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

P31

scholarly article

P356

10.1161/JAHA.116.005334

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28400368

http://www.w3.org/2001/XMLSchema#string

P932

5533023

http://www.w3.org/2001/XMLSchema#string